Sofinnova Investments, Inc.

Q2 2025 13F Holdings Report, Stock Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park, CA
Holdings as of
June 30, 2025
Value $
$1.47B
Num holdings
55
Date filed
8/14/2025, 03:09 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included NTRA, GILD, LLY, JAZZ, and VERA.
Previous filing
Q1 2025 - May 15, 2025
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2025 Q2 compared to 2025 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 8/14/2025

*Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., Sofinnova BioEquities GP LLC, and Sofinnova Synergy GP LLC.